new hardin memorial health · 2020. 1. 7. · health (hmh) and hardin memorial health foundation...

Annual Report 2019

Hardin Memorial Health

Oncology Service Line

Hardin Memorial Health | Oncology Service Line 2019 Annual Report | Page: 1Hardin Memorial Health | Oncology Service Line 2019 Annual Report | Page: 1

TABLE OF CONTENTS:

Mission, Vision, Uniqueness . . . . . . . . . . . . . . . 2

Comments from Cancer Committee Chair . . . . . 3

Comments from Cancer Liaison Physician. . . . . . 4

Meet Our Cancer Care Providers . . . . . . . . . . . . 5

2018 Data . . . . . . . . . . . . . . . . . . . . . . . . . . 6 - 7

Resource Center . . . . . . . . . . . . . . . . . . . . . . 8

Multidisciplinary Breast Cancer Care . . . . . . . . . 9 - 10

Multidisciplinary Lung Cancer Care . . . . . . . . . . 11 - 12

Clinical Trials . . . . . . . . . . . . . . . . . . . . . . . . 13

Supportive Care Clinic . . . . . . . . . . . . . . . . . . 14 - 15

Surviving Your Cancer Diagnosis . . . . . . . . . . . 15

Survivorship Clinic. . . . . . . . . . . . . . . . . . . . . 16

Psychosocial Services. . . . . . . . . . . . . . . . . . . 16

Financial Counseling Services . . . . . . . . . . . . . 17

Community Needs Assessment . . . . . . . . . . . . 18 - 20

Community Outreach . . . . . . . . . . . . . . . . . . 21 - 23

Physicians, Advanced Practice Clinicians & Staff . . 24

Hardin Memorial HealthOncology Service Line


HMH Cancer ProgramHardin Memorial Health is pleased to present its 2019 Cancer Program Annual Report. This report outlines the activities of the Cancer Program and newly diagnosed analytic cancer cases for 2018. Analytic cases are those that were either diagnosed and/or treated at our facility.

MissionTo exceed the physical, emotional and spiritual needs of our patients and their families by providing comprehensive, state-of-the art cancer treatments and therapies.

VisionTo provide hope and healing as the premier community cancer center in Kentucky.

Our UniquenessOur medical, surgical and radiation oncology specialists incorporate multidisciplinary treatments to provide advanced, cutting edge cancer expertise close to home.

Through our affi liation with the University of Kentucky Markey Cancer Center, the only National Cancer Institute (NCI) designated cancer program in Kentucky, we off er patients access to clinical trials and advanced cancer care expertise.

We are Commission on Cancer (CoC) accredited which recognizes our integrated continuum of care. Our comprehensive resources include prevention and screening, genetic counseling, nurse navigation, social work, fi nancial counseling, an onsite dedicated pharmacy, survivorship and palliative care.

We value our caring relationships with our patients and families.

Hardin Memorial Health | Oncology Service Line 2019 Annual Report | Page: 3

Comments from Donald E. Goodin, M.D.Cancer Committee Chair

At Hardin Memorial Health (HMH), comprehensive cancer care is of the utmost priority. We have access to the most current FDA approved treatment options for cancer and blood disorders as well as a broad range of support services throughout the spectrum of cancer care.

The HMH cancer program is American College of Surgeons Commission on Cancer (CoC) accredited. CoC establishes standards to ensure quality, multidisciplinary, and comprehensive cancer care delivery in healthcare settings. The HMH cancer team is in the process of obtaining American College of Radiology (ACR) Accreditation for radiation oncology. ACR accreditation is recognized as the gold standard in medical imaging. William Porter, MD has joined our radiation oncology team.

We continue to explore breast cancer accreditation through the National Accreditation Program for Breast Centers (NAPBC) and will move forward with that goal in the coming years. NAPBC is dedicated to the improvement of quality care and outcomes of patients with diseases of the breast including breast cancer.

Natalie Harper, MD, PhD has recently completed her fellowship training at the University of Kentucky and is now part of the hematology/oncology team. She will assume the role of Director of Research.

The HMH cancer program continues to enjoy a close working relationship with the University of Kentucky Markey Cancer Center Affi liate and Research Networks which allows our patients access to a wealth of cutting edge treatment and specialists as well as clinical trials.

The HMH cancer program continues to off er multidisciplinary lung and breast care. This provides an opportunity for physicians from multiple disciplines to evaluate patient specifi c treatment plans for these malignancies.

Donald E. Goodin, M.D.


William Porter, M.D.

Comments from William Porter, M.D. Cancer Liaison Physician

At Hardin Memorial Health (HMH), the cancer committee drives program development and is responsible for the metrics supporting the mission of high quality cancer care. The Cancer Liaison Physician (CLP) reports quality metrics and drills down on data measurements for further analysis. The CLP has access to data through the National Cancer Data Base (NCDB), Cancer Patient Data Management System (CPDMS) and hospital Cancer Registry data housed in the Kentucky Cancer Registry.

The NCDB provides access to cancer data and survival outcomes and compares our program with other cancer programs. Accountability and quality improvement measures are reported to the cancer committee and action plans are developed when our metrics are outside of expected benchmarks.

CPDMS provides cancer incidence and mortality data by disease site and counties/regions in Kentucky. This comparative data supports programmatic development and planning.

The Cancer Registry data provides a breakdown of diagnoses at HMH. The detail is used to manage stage at diagnosis, where treatment is provided, etc., allowing analysis of programs to support patients in our service area.


Kathryn Francescon, APRN-OCN, AANP

Specialty: Medical OncologyGraduate School: Spalding University, MSN

Cora Veza, M.D.Specialty: Hematology/OncologyMedical School: University of Santo Tomas, Manila, PhilippinesPracticing since 1985

Donald E. Goodin, M.D.Specialty: Hematology/OncologyBoard Certifi ed in Internal Medicine/Medical Oncology/HematologyMedical School: University of KentuckyPracticing since 2004

Meet Our Cancer Care Providers

Natalie Harper, M.D., Ph.D.Specialty: Hematology/OncologyBoard Certifi ed in Medical OncologyMedical School: University of KentuckyPracticing since 2019

William Porter, M.D.Specialty: Radiation Oncology Board Certifi ed in Radiation Oncology Medical School: Chicago Medical School at Rosalind Franklin UniversityPracticing since 2015

Stephen Toothaker, M.D.Specialty: Hematology/OncologyBoard Certifi ed in Medical Oncology/HematologyMedical School: DartmouthPracticing since 2008

Kelly White, APRN-OCN, CPCSpecialty: Radiation OncologyGraduate School: Spalding University, MSN

Richard Seither, M.D.Specialty: Radiation Oncology Board Certifi ed in Radiation Oncology Medical School: Louisiana State University Practicing since 1992


2018 Top 5 Diagnoses180

160

140

120

100

80

60

40

20

0

Lung Breast Prostate Colon Bladder 171 164 110 60 58

2018 Stage Breakdown: All Diagnoses

300

250

200

150

100

50

0

2018 Data

Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 Unknown75 282 121 130 173 125


2018 Case Diagnosis Location and Treatment

700

600

500

400

300

200

100

0

K E N T U C K Y

Hardin

Breckinridge

Grayson

Hart

Larue

MeadeBullitt

Nelson

Taylor

Green

AdairMedcalfeBarren

EdmonsonButler

Warren

Muhlenburg

OhioMcClean

Daviess

Hancock

Jeff erson

Spencer

Shelby

Anderson

Washington

Marion

Casey

Pulaski

Lincoln

Boyle

Mercer

Woodford

Franklin

HarrisonPerry

SpencerWarrick

I N D I A N A

52

86

442

94

139

7

72

86

29

Primary Secondary Tertiary

2018 Cases by Service Area

Diagnosed at HMH & treated

elsewhere99

Diagnosed & treated at HMH

675

Diagnosed elsewhere &

treated at HMH 117

Diagnosed in staff physician offi ce &

treated at HMH 34


On August 9, 2018, Hardin Memorial

Health (HMH) and Hardin Memorial

Health Foundation (HMHF) opened a

new HMH Cancer Care Resource Center

on Robinbrooke Boulevard adjacent to

the HMH Cancer Care Center. This facility

provides patients, family and community

members with a wide range of cancer

information and resources from treatment

options, to supportive care at no charge.

HMHF provided $28,000 to fund the construction

and furnishings of the HMH Cancer Care Resource

Center. The 2018 Purses, Pumps and Prevention

community event generated over $21,000 for

the project.

Hours for the HMH Cancer Care Resource Center are

8 a.m. – 4:30 p.m. (Monday – Friday).

A special thank you to the HMH Cancer Care Resource Center Committee that championed

construction, design and programing of the resource center as well as the generous supporting

community organizations.

Cancer Care Resource Center

Committee:

Karen Blaiklock, HMH Communications/Community Relations

Kelli Bush, Community Advocate

D. Dee Shaw, Community Advocate

Jason Hart, HMH Facilities Management

Kim Jones, HMH Cancer Care

Kristina Davis, HMH Cancer Care

Renee Perry, HMH Cancer Care

Melissa Rock, HMH Cancer Care

Cathy Wilson, Community Advocate

Supporting Community Organizations:

Ange Deaton, Owner, FINE House & Garden

Empire Beauty School

Hedda Jenkins, Owner/Interior Designer, ReCreations

Louisville Bats


National Accreditation Program for Breast Centers (NAPBC)

Hardin Memorial Health supports a breast center of

excellence methodology. The multidisciplinary breast team

is dedicated to the improvement of quality outcomes for

patients with diseases of the breast through evidence-

based standards. The Breast Program Leadership Committee

under the direction of Dr. Karen Johnson Brunkhorst, Breast

Program Director, is in the process of applying for NAPBC

accreditation.

We value the importance of:

• A multidisciplinary team approach to coordinate the best care and treatment options available.

• Access to breast-specifi c information, education and support.

• Breast center data collection on quality indicators for subspecialties involved in breast cancer diagnosis and treatment.

• Ongoing monitoring and improvement of care.

• Information about participation in clinical trials and new treatment options.

“At HMH, we strive for high quality breast care and continuously benchmark our outcomes against national standards. We want to achieve the highest quality standards available. Patients will receive the same high quality care close to home.”

Dr. Johnson Brunkhorst

Breast Cancer Cases2014 - 2018

200

150

100

50

02014 2015 2016 2017 2018 139 158 134 160 164

Karen Johnson Brunkhorst, M.D. General Surgery, Breast Program Director

Multidisciplinary Breast Cancer Care


Multidisciplinary Breast Cancer Care Team

Audrey Cleaver, BSN, RNNurse Navigator

Jesse Bryant, M.D. Radiology

Laura Barkley, M.D.Radiology, Co-Medical Director Women’s Diagnostic Services

Stephen Toothaker, M.D.Hematology/Oncology

Richard Seither, M.D.Radiation Oncology

Srikala, Ramasamy, M.D.Radiology, Co-Medical Director Women’s Diagnostic Services

Jessica Clevenger, M.D. Pathology

Donald Goodin, M.D. Hematology/Oncology

Gwen Godfrey, D.O.Pathology

Cora Veza, M.D.Hematology/Oncology

Stewart Couch, M.D.Radiology

David Elliott, M.D.Pathology

Ashley Kerekes, M.D.Plastic & ReconstructiveSurgery

Karen Johnson Brunkhorst, M.D. General Surgery, Breast Program Director

William Porter, M.D.Radiation Oncology

Natalie Harper, M.D., Ph.D.Hematology/Oncology

Andrea Walker, M.D.Radiology


Multidisciplinary Lung Cancer Care

The HMH multidisciplinary lung program began in

November 2016 minimizing the number of patient

visits while providing comprehensive multidisciplinary

cancer care close to home. Patients with lung nodules,

suspicious diagnostic fi ndings or a newly diagnosed

lung cancer are seen in clinic on Tuesday afternoon

following a lung tumor board. The multidisciplinary

team is featured on the next page.

Since 2015 Hardin Memorial Health has seen an

increase in the overall number of lung cancers

that have been diagnosed. With this increase, the

proportion of stage I – III cases to stage IV cases has

changed. This means that more patients are being

diagnosed while still in a curative stage (See Exhibit A).

This change in diagnosing lung cancers earlier can be

attributed to a robust LDCT screening program, nurse

navigation and evidence-based high quality care.

Hardin Memorial completed almost 850 Low Dose CT

Lung Scans in 2018 (See Exhibit B), along with seeing

patients in our weekly Multidisciplinary Lung Clinic.

The Multidisciplinary Lung Clinic has fi ne-tuned the

population that seeks to only include patients with

lung nodules 8mm or greater. This has decreased the

number of patients being seen, however the number

of cancer diagnoses has remained steady and is on

track to increase in 2019 (See Exhibit C).

Connie Barnes, Lung Nurse Navigator states, “The

biggest impact I bring to the weekly multidisciplinary

lung program is getting those suspicious nodules into

the clinic rapidly. We average two to fi ve incidental

fi ndings per week. Not all nodules or masses are

malignant, but a good percentage will move forward

very quickly for a diagnosis and treatment.”

Exhibit B Number Of Low Dose CT Scans

1250

1000

750

500

250

02017 2018 2019

Projected

100

80

60

40

20

0

Exhibit A Lung Cancer Diagnoses By Stage

2015 2016 2017 2018

Stage I-III Stage IV

600

400

200

0

New Pulmonology Oncology Cancer Patients Visits Visits Diagnoses

Exhibit C Lung Clinic Data

2017 2018 2019 Projected

594

848

1150


Multidisciplinary Lung Cancer Care Team

Navin Kaini, M.D.Pulmonary/Critical Care

Kelli Mathew, D.O.Pulmonary/Critical Care

Aaron Mulhall, M.D. Pulmonary/Critical Care

Jordan Miller, D.O.Cardiothoracic SurgeryUK HealthCare

Richard Seither, M.D.Radiation Oncology

Connie Barnes, MSN, RN, OCNNurse Navigator

Gwen Godfrey, D.O.Pathology

Ronald Wurth, M.D. Radiology

Jesse Bryant, M.D. Radiology

William Cundiff , D.O. Pulmonary/Critical Care

Jessica Clevenger, M.D. Pathology

Donald Goodin, M.D. Hematology/Oncology

Stewart Couch, M.D. Radiology

Cora Veza, M.D.Hematology/Oncology

Stephen Toothaker, M.D.Hematology/Oncology

William Porter, M.D.Radiation Oncology

Natalie Harper, M.D., Ph.D.Hematology/Oncology


HMH Clinical Trial ParticipationThe mission of the clinical research program is to reduce the impact of cancer by increasing awareness of new evidence, trends and practice standards. It is our goal to increase the involvement of those in the community to participate in cancer research activities creating more opportunities for community based research services.

University of Kentucky Clinical Trial Opportunities• Hardin Memorial Health is a member of both the research and affi liate

networks of the University of Kentucky Markey Cancer Center, the state’s only National Cancer Institute (NCI) designated cancer center. HMH participates in the NCI’s National Cancer Trials Network through the University of Kentucky, allowing access to both national clinical trials and advanced cancer expertise.

• The Molecular Tumor Board (MTB) is a forum of expert clinicians and scientists that analyzes tumor genotypes and molecular abnormalities from next generation sequencing test results in order to recommend patient-specifi c targeted therapies. The MTB provides a gateway for Markey researchers to learn more about which genetic mutations cause certain cancers in patients throughout the Commonwealth. Knowing which mutations are found in Kentucky’s cancer population can help with developing or recruiting targeted clinical trials for patients. Through this observational study, Markey is able to create a rich molecular database connected to the Kentucky Cancer Registry, providing researchers with a wealth of information for drug development as well as population-based studies.

Clinical Trial Volumes

In 2018, clinical trial accrual again exceeded accreditation requirements of 4% for a comprehensive community cancer program (see chart below). We exceeded our goal of 36 by 28% accruing 50 trial participants.

2018 Clinical Trial Accrual

Kentucky Lung Education Awareness Detection and Survivorship (LEADS) 17

Optimization of Smoking Cessation Strategies (MOST) 4

University of Kentucky Molecular Tumor Board 8

NCI Trials 11

Referrals to other programs 12

Total (28% Increase) 50

Clinical Trial Accrual by Year 2015 - 2018

50

25

0

2015 2016 2017 2018 16 21 39 50

HMH also participates in the National Radiology Data Registry (NRDR) dedicated to low dose CT screenings. This research project builds on the ongoing screening of patients age 55-77 with a 30-pack year smoking history, who either currently smoke or quit within the past 15 years. This rich data will be used to learn more about lung cancer. Our participation increased by 66% from last year from 300 patients to over 500.


Supportive Care Clinic

In December of 2017, HMH Cancer Care, in partnership with Hosparus of Louisville, implemented a provider

driven Supportive Care Clinic. Dr. Cory Lucas (Palliative/Hosparus Provider), Jeanette Settle (RN), and Kristina

Davis (Oncology Social Worker), see patients every Friday.

The purpose of the clinic is to discuss goals of care, symptom management, advanced care planning and

spiritual counseling for patients with late stage cancers. Patients being treated with palliative intent in

radiation oncology and medical oncology are off ered a referral to the Supportive Care Clinic. The goal is

to establish a patient in the Supportive Care Clinic early in the journey to support and complement the

prescribed treatment plan.

Below is a graph of referrals to the Supportive Care Clinic through August 2019. The Supportive Care Clinic

team is currently collaborating with our oncology providers and leadership to increase the number of

referrals to the Supportive Care Clinic and improve the timeliness of these referrals.

January - August 2019 Supportive Care Referrals

7

6

5

4

3

2

1

0JAN FEB MAR APR MAY JUN JUL AUG

4 6 1 3 1 3 4 3

Jeanette Settle, BSN, RN, OCNSurvivorship Nurse Navigator

Cory Lucas, MDPalliative Care/Hosparus Provider

Kristina Davis, MSW, CSWOncology Social Worker


Surviving Your Cancer DiagnosisAt HMH, patients completing curative treatment receive a survivorship care plan and treatment summary.

This information provides the patient with detail about their treatment, information on follow up

recommendations, and ongoing screening.

“As the survivorship nurse navigator, it is my responsibility to connect with patients, providing a contact for

ongoing support. Patients appreciate the personal contact and often reach for ongoing care,” says Jeanette

Settle, Survivorship Nurse Navigator.

January - August 2019 Supportive Care Clinic

7

6

5

4

3

2

1

0JAN FEB MAR APR MAY JUN JUL AUG

4-3 6-4 1-1 3-2 1-1 3-2 4-2 3-1

# of Patient Referrals # of Patients Seen

In the next graph, a comparison is shown between referrals and patients seen through August 2019 . The goal is

to close the gap between referrals and patients seen through earlier referrals to the Supportive Care Clinic. Often

patients are not referred until end of life when a Hosparus admission or death occurs prior to the visit.

Jeanette Settle, BSN, RN, OCNSurvivorship Nurse Navigator

2015 - 2018 Survivorship Care Plan Distribution

400

300

200

100

02015 2016 2017 2018 13 28 324 299

Plan

s G

iven


Survivorship ClinicIn 2018, a Survivorship Clinic was established. A nurse practitioner evaluates the

patient’s current versus pre-treatment status and develops strategies to improve

conditioning and healthy lifestyles (e.g. Physical Therapy, Nutrition, Alternative

Therapies), and assists in scheduling screening for other cancers. Patients

are scheduled in the clinic after the last curative treatment appointment. A

survivorship care plan is also presented at this time. The next appointment is with

the physician for specifi c diagnosis follow up.

HMH is excited to provide this best practice as a high-quality service for our

patients.Kelly White, APRN,ONC, CPCMedical Oncology

Psychosocial ServicesTo address psychosocial issues experienced by patients with cancer, the HMH

Cancer Program performs distress screening for all new cancer patients, as

needed during treatment, and at survivorship appointments. Our oncology

social worker, Kristina Davis, assesses psychological, social, fi nancial and

behavioral issues that may interfere with a patient’s treatment plan and

adversely aff ect treatment outcomes.

Kristina meets with cancer patients in radiation oncology, the infusion center

and multidisciplinary clinics to address barriers to care that arise after the new

patient appointment. “At the fi rst appointment, my time is spent on emotions

dealing with the diagnosis. Often, it is

when treatment is in process that barriers

to care with transportation and cost arise,”

states Kristina.

This year, the top interventions requiring

actions were emotional support, fi nancial

assistance, transportation assistance, and

support groups.

Kristina Davis, MSW, CSWOncology Social Worker


Financial Counseling ServicesThe HMH Cancer Program off ers all cancer patients access to fi nancial counseling services. The cost of

treatment can be prohibitive due to expensive co-pays and out-of-pocket expenses for services.

Through a recent assessment of cancer patients in active treatment, most have limited income with

33% of our patients at or below poverty level. Patients indicated cost of medication as the reason for not

refi lling prescriptions.

Hanna Price provides fi nancial counseling services at any time during a patient’s treatment. Most patients

are identifi ed at the new patient appointment by the oncology social worker through the distress

screening tool. The oncology social worker refers the patient to Hanna to collect information to support

drug assistance, charitable options, and other services that support patient adherence to the prescribed

treatment regimen. This team oriented approach to patient care closes the gap on missed appointments

and decisions not to go forward with treatment.

In 2019, 177 applications were approved for co-pay assistance, 46 applications were approved for free

medication, and 115 Financial Assistance Program applications were completed.*

“The majority of my time is spent processing applications. If there is a program available, I want to

make sure our patients are enrolled. Often the thought of the fi nancial obligation weighs as heavy as

the diagnosis. The last thing I want to hear is a patient does not move forward w ith treatment or stops

treatment due to cost. That’s where the oncology social worker and I step in, and work together to fi nd a

program or solution to ensure our patients receive the care they deserve,” states Hanna.

Hanna PriceOncology Financial Navigator

* Applications processed through December 1, 2019.


Community Outreach

Prevention Prevention Goal:

Prevention, Refl ect, Assess, You (P.R.A.Y.) Breast Cancer

Awareness Program

In 2019, our goal was to educate more underserved area residents about personal breast health. This was accomplished through business and industry clients, health fairs, Wellness On Wheels (WOW) van visits and or church events. We additionally established an African American advocate to support awareness for breast education and worked to improve tracking of race/ethnicity for outreach opportunities.

Hardin Memorial Hospital partnered with First Baptist

Church in Elizabethtown to provide a Breast Cancer Awareness event, P.R.A.Y. Women

were educated on the importance of mammograms by Dr. Andrea Watson. Pre and

post-tests were completed to assess the attendees’ compliance with mammography

screening.

WOW counseled 63 clients, distributed information to 38 women (2 African Americans,

1 Hispanic, and 60 Caucasian) and provided follow up phone calls with 11 clients on

mammograms. Additionally, one African American health fair was scheduled, with 100

attendees and 9 surveys were completed.

P.R.A.Y.

Survey Event Results

of women hadmammograms in

the last 2 years

69%completed yearly

clinical breastexam

89%plan to

schedule amammogram

40%motivated to schedule as aresult of the

program

26%undeterminedon whether to

schedule amammogram

57%


Tobacco Prevention Program

During 2019, implementation of Botvin Life Skills tobacco reduction pilot program

continued at the Larue County Middle School. Tobacco prevention is a top strategy and

community need for Hardin Memorial Hospital patient population. Smoking incidence,

lung cancer incidence and mortality are high for patients in our regional counties. Botvin

Life Skills tobacco reduction evidence-based prevention program cuts tobacco use for

middle school students by up to 80% with eff ects lasting up to 6 years.

In School Year 2018/2019, Larue County Middle School, 205 students attended 4

sessions; 190 students attended 3 sessions; and 193 attended 2 sessions. 172 students

took the post-test. After completion of the 9 education sessions over 3 school years,

3% of the eighth grade students, indicated, “Defi nitely would not say “no” to accept a

tobacco product.” 69% indicated, “Defi nitely say “no” to accept a cigarette.”

20182019 BOTVIN POST TEST 8TH GRADE

How likely would you be to say “no” Defi nitely Would Probably Would Not Sure If I Probably Would Defi nitely Wouldwhen someone off ers you a cigarette. Say “No” Say “No” Would Say “No” Not Say “No” Not Say “No”

69% 16% 8% 4% 3%

Screening Goal:

Prevention, Refl ect, Assess, You (P.R.A.Y.) Breast Cancer Awareness Program

Increase the number of service area underserved populations participating in screening

mammography.

In our service area, breast cancer is the 2nd highest diagnosis. In Hardin County, the

African American population is 12% of the residents. Incidence and mortality from

breast cancer is higher for underserved populations, specifi cally African American. A

review of mammograms for 2018 indicates less than 7% of African Americans complete

an annual screening.

As demonstrated on p. 20, year-to-year data from 2018 to 2019 comparing Q.1 and Q.2,

indicates more African American clients completed a screening mammogram.


Colorectal Cancer - FIT Kits

Increase the number of service area residents reached for Fecal Immunochemical Test (FIT)

testing through business and industry clients and underserved populations participating

in health fairs, WOW van visits and or church events.

51 FIT OC Light kits were distributed from 1/17/2019 to 10/31/2019 within 9 counties.

Following ACS guidelines for screening protocol, various venues were utilized to reach our

community: 4 health fairs, 1 church, 15 WOW regional visits.

Partnering with the Kentucky Cancer Link, follow up phone calls and letters were placed to

fi nd the following results: 3 positive, 33 negative, 1 invalid kit (replacement was mailed), 15

noncompliant and 1 invalid colonoscopy status after positive, 1 was moving out-of- state

and would share with new MD; 1 declined assistance and requested to share info with MD;

1 was returning to MD for shared decision; and unable to be reached after that.

The campaign covers 14 counties by off ering the kits during wellness coaching on the

WOW, 2 African American events, with the addition of community festivals and off ering FIT

kits in conjunction with fl u immunizations at business/industries.

Although the focus of the goal was prevention through screening, the topic of colorectal

cancer awareness is a subject matter we continue to creatively investigate approaches to

reach clients to encourage early detection.

SCREENING MAMMOGRAMS AT HMH DIAGNOSTIC CENTERS

2018 CY 2019 CY

Quarter 1 Quarter 2 Quarter 3 Quarter 4 Quarter 1 Quarter 2

American Indian or Alaska Native 1 2 0 1 1 2

Asian 41 29 51 47 39 38

Black or African American 196 216 202 241 240 250

Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480

or Alaska Native 1 2 0 1 1 2

Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480


Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480


Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480

2018 CY 2019 CY


Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480


Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480


Asian 41 29 51 47 39 38


Other 8 9 15 31 20 8

White 2,909 3,051 3,048 3,347 3,420 3,182

Total 3,155 3,307 3,316 3,694 3,720 3,480

Barriers to reaching additional African American members and churches were due to

scheduling confl icts for Fall 2019, but several organizations reached out after the pilot

P.R.A.Y. event requesting similar events for 2020.


Other Prevention AndScreening Initiatives

National Colorectal Cancer Awareness MonthThe Incredible ColonMarch 9, 2019

During the month of March, HMH educated clients about colorectal cancer and the importance of early

detection screenings. The attendees had the opportunity to explore the Incredible Colon, a 20 foot infl atable

interactive medical model at the event. Registered nurses with HMH Cancer Care Center and Endoscopy ser-

vices were present to engage participants in a discussion regarding risk factors, prevention tips and screening

guidelines for colorectal cancer. 150 community members visited the display in the Towne Mall center court

and completed a colon cancer screening survey.

National Cancer Control MonthPurses, Pumps and Prevention: A Cancer Awareness Social April 25, 2019

Recognizing April is National Cancer Control Month, Hardin Memorial Health held a community

cancer prevention awareness program featuring a fashion show, dinner and educational program

for participants to learn about breast, colorectal, cervical, skin and lung cancer prevention. Cancer

prevention educational handouts were provided in addition to local support and resources. Participants

were encouraged to recognize cancer prevention screening recommended guidelines and seek

appropriate medical assistance.


Skin Cancer Screening May 6, 2019

In recognition of National Skin Cancer Detection and Prevention Month, a free skin

cancer screening was provided: 43 community members were screened following the

American Academy of Dermatology (AAD) screening guidelines with the assistance

of 2 local dermatologists. Educational materials from the American Academy of

Dermatology and National Cancer Institute were distributed to promote skin cancer

prevention. Demographics below:

Average Age: 52

Participants

Participants completed a screening evaluation noting: 49% of the participants stated

they regularly use sunscreen; 54% perform monthly self-preventative skin check

examinations; and 88% indicated they will start checking their skin monthly for

changes. Follow up phone calls were conducted by a registered nurse to the 9 referring

participants reaching 4 clients.

5 38

• 9 referred for follow-up (1 male and 8 females)

• 2 ruled out basal cell carcinoma

Social Media

Various platforms of social media, including Facebook, Internet hmh.net, and YouTube

were utilized to help our regional community learn more about cancer prevention,

education and various cancer support group opportunities.


Skin Cancer Prevention Education and Awareness:

Utilizing the Environmental Protection Agency (EPA) Sun Safety program “SunWise,” the

program reached over 422 community members at community festivals and summer

school programs from April-July. Sunscreen and education regarding UV radiation was

shared and distributed throughout our regional service area.

Additionally, 92 community clients who visited the WOW mobile health unit during

regional visits, were counseled regarding skin cancer prevention based upon their risk

factor. 59 of the 92 received educational information and 15 clients received follow up.

Breast Cancer Awareness MonthOctober 2019

During the month of October, Hardin Memorial Health participated in community

outreach through the following activities: Tails & TaTas and Judy Walden 5K.

Community members participated in raising funds to support the HMH Cancer

Resource Center. They also received educational information on the importance of

early detection through mammography screenings.

Tails and Ta Ta’sBreast Cancer Awareness 5K Run/WalkOctober 12, 2019

Judy Walden 5KOctober 26, 2019

Submitted by: Karen G. Blaiklock, MS, RN Communications & Community Relations Director, HMHCommunity Outreach Coordinator, Cancer Committee


Physicians, Advanced Practice Clinicians & Staff

521 Robinbrooke BlvdElizabethtown, Kentucky 42701

www.hmh.net

Medical Oncology:

Donald Goodin, MDNatalie Harper, MD, PhDStephen Toothaker, MDDan Martin, PT, MPT – AVP of Oncology and Rehabilitation ServicesMelissa Rock, BSN, RN, OCN – Director of OperationsMorgan Gerage, BSN, RN, OCN – Clinical ManagerRocky Hardesty, RN, OCNDiane Drobny, BSN, RN, OCN, CCRPJeanette Settle, BSN, RN, OCNSara Robinette, BSN, RN, OCNAnna Akins, RN, OCNPaula Bray, RN, OCNDebora Kirby, CPCJoyce Williams, BSN, RN, OCNPamela Dodd, BSN, RN, OCNMary Harned, MSN, RNConnie Barnes, MSN, RN, OCNKathryn Francescon, APRN, OCNDeborah Lemons, RN, OCNRhonda Judd, CMARenee Griner, RRT, BSN, RNAudrey Cleaver, BSN, RNJameka Milton, BSN, RNKristen Boone, BSN, RNMegan Smith, MA

Kimberly Jones, BSN, RNBrandon Thompson, RNAbby Henderson, MAJames Taylor, RN

Pharmacy:

Jackee Clark, PharmD, BCPSMike Senay, PharmD, RPhJessica Smith, CPhTMegan Mier, CPhT

Radiation Oncology:

William Porter, MDRichard Seither, MDKelly White, APRN, OCN, CPCMelissa Hardin, BSN, OCNCharity Johnston, BSN, OCNPhyllis Raymer, SecretarySara Stivers, CPC, SecretaryJohn Sena, RT(R)(T), CMDNathan Thompson, MS, DABRMary Ann Squires, RT(R)(T)Eyvette Fisher, BSRT(R)(CT)(T)Amanda Smith, BSRT(R)(T)Amber Robey, BSRT(R)(T)Scott Goodman, BSRT(R)(T), MBA-HCM

new hardin memorial health · 2020. 1. 7. · health (hmh) and hardin memorial health foundation...

Documents